Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)

ClinicalTrials.gov ID: NCT02849951

Public ClinicalTrials.gov record NCT02849951. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 25, 2026, 9:15 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of a 12-week Add-on Treatment With LT-02 vs. Placebo in Subjects With Ulcerative Colitis Refractory to Standard Treatment With Mesalamine

Study identification

NCT ID
NCT02849951
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Prometheus Laboratories
Industry
Enrollment
25 participants

Conditions and interventions

Interventions

  • LT-02 Drug
  • LT-02 Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2016
Primary completion
Feb 28, 2019
Completion
Jul 31, 2019
Last update posted
Jun 14, 2017

2016 – 2019

United States locations

U.S. sites
45
U.S. states
23
U.S. cities
42
Facility City State ZIP Site status
Prometheus Site 24 Phoenix Arizona 85018
Prometheus Site 10 Little Rock Arkansas 72205
Prometheus Site 15 Chula Vista California 91910
Prometheus Site 42 Lancaster California 93534
Prometheus Site 30 Oceanside California 92056
Prometheus Site 28 Rialto California 92377
Prometheus Site 2 Ventura California 93003
Prometheus Site 27 Lafayette Colorado 80026
Prometheus Site 45 Lone Tree Colorado 80124
Prometheus Site 35 Clearwater Florida 33756
Prometheus Site 17 Fort Lauderdale Florida 33319
Prometheus Site 55 Hialeah Florida 33016
Prometheus Site 8 Naples Florida 34102
Prometheus Site 13 Naples Florida 34110
Prometheus Site 36 Orlando Florida 32803
Prometheus Site 44 Orlando Florida 32807
Prometheus Site 37 Athens Georgia 30607
Prometheus Site 11 Decatur Georgia 30033
Prometheus Site 53 Chicago Illinois 60624
Prometheus Site 54 Hoffman Estates Illinois 60169
Prometheus Site 20 Topeka Kansas 66606
Prometheus Site 4 Shreveport Louisiana 71105
Prometheus Site 5 Chevy Chase Maryland 20815
Prometheus Research Site 1 Brockton Massachusetts 02379
Prometheus Site 6 Chesterfield Michigan 48047
Prometheus Site 51 Southfield Michigan 48034
Prometheus Site 48 Wyoming Michigan 49519
Prometheus Site 31 Plymouth Minnesota 55446
Prometheus Site 40 St Louis Missouri 63128
Prometheus Site 21 Lebanon New Hampshire 03756
Prometheus Site 22 Great Neck New York 11021
Prometheus Site 33 Poughkeepsie New York 12601
Prometheus Site 26 The Bronx New York 10467
Prometheus Site 41 Greenville North Carolina 27834
Prometheus Site 32 Kinston North Carolina 28501
Prometheus Site 43 Columbia South Carolina 29203
Prometheus Site 7 Rapid City South Dakota 57701
Prometheus Site 49 Houston Texas 77090
Prometheus Site 39 Humble Texas 77338
Prometheus Site 47 San Antonio Texas 78229
Prometheus Site 9 San Antonio Texas 78229
Prometheus Site 23 Orem Utah 84058
Prometheus Site 25 Salt Lake City Utah 84107
Prometheus Site 34 Charlottesville Virginia 22911
Prometheus Site 12 Richland Washington 99352

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02849951, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 14, 2017 · Synced Jul 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02849951 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →